Study S002371

"Efficacy of Once-weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05249881
Study type: INTERVENTIONAL
Phase: EARLY_PHASE1
Masking: NONE
Status: UNKNOWN
Enrollment: 300
Start: 2022-03-10
Primary completion: 2022-12
Lead sponsor: Aga Khan University
Conditions: Diabetes Mellitus, Type 2; Weight Change, Body
Interventions: DRUG:Semaglutide Pen Injector
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in glycemic Index in Diabetes mellitus type-2 Patients [3 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.